C4 Therapeutics Shares Are Trading Higher After the Company Announced a Strategic Discovery Collaboration With Merck KGaA Against Critical Oncogenic Proteins, in Which the Company Will Receive a $16 Million Upfront Payment
C4 Therapeutics的股价走高，此前该公司宣布与默沙东KGaA进行针对关键致癌蛋白的战略发现合作，该公司将获得1,600万美元的预付款